APONVIE (NDA216457)- (32MG/4.4ML (7.2MG/ML))

Generic Name	APREPITANT	Innovator	HERON THERAPS INC
Dosage	32MG/4.4ML (7.2MG/ML)
ParaIV Filing	Yes	505(b)2 Filing	Yes
Last Patent Expiry	2035-Sep-18	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	APONVIE is a substance P/neurokinin-1 (NK1) receptor antagonist, indicated for the prevention of postoperative nausea and vomiting (PONV) in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	7

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
32MG/4.4ML (7.2MG/ML)	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of APONVIE